Annual accounts receivable:
$108.28M-$188.96M(-63.57%)Summary
- As of today (May 21, 2025), NVAX annual accounts receivable is $108.28 million, with the most recent change of -$188.96 million (-63.57%) on December 31, 2024.
- During the last 3 years, NVAX annual accounts receivable has fallen by -$346.71 million (-76.20%).
- NVAX annual accounts receivable is now -76.20% below its all-time high of $454.99 million, reached on December 31, 2021.
Performance
NVAX Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$44.51M-$63.77M(-58.90%)Summary
- As of today (May 21, 2025), NVAX quarterly accounts receivable is $44.51 million, with the most recent change of -$63.77 million (-58.90%) on March 31, 2025.
- Over the past year, NVAX quarterly accounts receivable has increased by +$23.13 million (+108.19%).
- NVAX quarterly accounts receivable is now -90.69% below its all-time high of $478.16 million, reached on March 31, 2022.
Performance
NVAX Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
NVAX Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -63.6% | +108.2% |
| 3 y3 years | -76.2% | -90.7% |
| 5 y5 years | +1343.8% | +100.0% |
NVAX Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.2% | +31.4% | -90.7% | +108.2% |
| 5 y | 5-year | -76.2% | +1343.8% | -90.7% | >+9999.0% |
| alltime | all time | -76.2% | >+9999.0% | -90.7% | >+9999.0% |
NVAX Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $44.51M(-58.9%) |
| Dec 2024 | $108.28M(-63.6%) | $108.28M(+14.0%) |
| Sep 2024 | - | $94.96M(+195.8%) |
| Jun 2024 | - | $32.10M(+50.2%) |
| Mar 2024 | - | $21.38M(-92.8%) |
| Dec 2023 | $297.24M(+260.8%) | $297.24M(+140.4%) |
| Sep 2023 | - | $123.66M(-68.7%) |
| Jun 2023 | - | $394.89M(+249.9%) |
| Mar 2023 | - | $112.85M(+37.0%) |
| Dec 2022 | $82.38M(-81.9%) | $82.38M(-26.2%) |
| Sep 2022 | - | $111.64M(-42.6%) |
| Jun 2022 | - | $194.53M(-59.3%) |
| Mar 2022 | - | $478.16M(+5.1%) |
| Dec 2021 | $454.99M(+73.7%) | $454.99M(+504.4%) |
| Sep 2021 | - | $75.28M(+50.6%) |
| Jun 2021 | - | $49.99M(-12.1%) |
| Mar 2021 | - | $56.90M(-78.3%) |
| Dec 2020 | $262.01M(+3393.5%) | $262.01M(+2020.7%) |
| Sep 2020 | - | $12.36M(>+9900.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $7.50M(>+9900.0%) | $7.50M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2016 | - | $591.00K(+62.8%) |
| Jun 2016 | - | $363.00K(-10.6%) |
| Mar 2016 | - | $406.00K(-82.5%) |
| Dec 2015 | $2.32M(-69.1%) | $2.32M(+5.6%) |
| Sep 2015 | - | $2.20M(-6.2%) |
| Jun 2015 | - | $2.34M(-64.9%) |
| Mar 2015 | - | $6.67M(-11.1%) |
| Dec 2014 | $7.51M(+293.0%) | $7.51M(+162.7%) |
| Sep 2014 | - | $2.86M(-23.1%) |
| Jun 2014 | - | $3.72M(-16.7%) |
| Mar 2014 | - | $4.47M(+133.7%) |
| Dec 2013 | $1.91M(+89.0%) | $1.91M(0.0%) |
| Sep 2013 | - | $1.91M(+110.7%) |
| Jun 2013 | - | $907.00K(-65.1%) |
| Mar 2013 | - | $2.60M(+157.4%) |
| Dec 2012 | $1.01M | $1.01M(-59.1%) |
| Sep 2012 | - | $2.47M(+64.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $1.50M(-13.2%) |
| Mar 2012 | - | $1.73M(-12.2%) |
| Dec 2011 | $1.97M(+3538.9%) | $1.97M(>+9900.0%) |
| Sep 2011 | - | $17.00K(-99.1%) |
| Jun 2011 | - | $1.83M(-27.2%) |
| Mar 2011 | - | $2.52M(+4561.1%) |
| Dec 2010 | $54.00K(-79.1%) | $54.00K(-91.0%) |
| Sep 2010 | - | $599.00K(+68.3%) |
| Jun 2010 | - | $356.00K(+54.1%) |
| Mar 2010 | - | $231.00K(-10.5%) |
| Dec 2009 | $258.00K(-79.7%) | $258.00K(-21.8%) |
| Sep 2008 | - | $330.00K(+0.9%) |
| Jun 2008 | - | $327.00K(-49.5%) |
| Mar 2008 | - | $647.00K(-59.6%) |
| Sep 2007 | - | $1.60M(+103.4%) |
| Jun 2007 | - | $787.00K(-13.1%) |
| Mar 2007 | - | $906.00K(-28.9%) |
| Dec 2006 | $1.27M(-64.3%) | $1.27M(-59.2%) |
| Sep 2006 | - | $3.13M(-18.3%) |
| Jun 2006 | - | $3.83M(+6.2%) |
| Mar 2006 | - | $3.60M(+0.8%) |
| Dec 2005 | $3.57M(+331.8%) | $3.57M(+211.3%) |
| Sep 2005 | - | $1.15M(+1.2%) |
| Jun 2005 | - | $1.13M(+81.0%) |
| Mar 2005 | - | $626.00K(-24.3%) |
| Dec 2004 | $827.00K(-57.8%) | $827.00K(-53.5%) |
| Sep 2004 | - | $1.78M(-46.0%) |
| Jun 2004 | - | $3.30M(+42.3%) |
| Mar 2004 | - | $2.32M(+18.3%) |
| Dec 2003 | $1.96M(+4.1%) | $1.96M(-31.5%) |
| Sep 2003 | - | $2.86M(+52.8%) |
| Jun 2003 | - | $1.87M(+47.3%) |
| Mar 2003 | - | $1.27M(-32.5%) |
| Dec 2002 | $1.88M(-51.5%) | $1.88M(+24.3%) |
| Sep 2002 | - | $1.51M(-53.7%) |
| Jun 2002 | - | $3.27M(-16.1%) |
| Mar 2002 | - | $3.90M(+0.6%) |
| Dec 2001 | $3.88M | $3.88M(+28.8%) |
| Sep 2001 | - | $3.01M(+20.7%) |
| Jun 2001 | - | $2.50M(+44.6%) |
| Mar 2001 | - | $1.73M |
FAQ
- What is Novavax annual accounts receivable?
- What is the all time high annual accounts receivable for Novavax?
- What is Novavax annual accounts receivable year-on-year change?
- What is Novavax quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Novavax?
- What is Novavax quarterly accounts receivable year-on-year change?
What is Novavax annual accounts receivable?
The current annual accounts receivable of NVAX is $108.28M
What is the all time high annual accounts receivable for Novavax?
Novavax all-time high annual accounts receivable is $454.99M
What is Novavax annual accounts receivable year-on-year change?
Over the past year, NVAX annual accounts receivable has changed by -$188.96M (-63.57%)
What is Novavax quarterly accounts receivable?
The current quarterly accounts receivable of NVAX is $44.51M
What is the all time high quarterly accounts receivable for Novavax?
Novavax all-time high quarterly accounts receivable is $478.16M
What is Novavax quarterly accounts receivable year-on-year change?
Over the past year, NVAX quarterly accounts receivable has changed by +$23.13M (+108.19%)